Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 946-954

  Li, Christopher I ^a   Daling, Janet R ^a   Malone, Kathleen E ^a   Bernstein, Leslie ^b   Marchbanks, Polly A ^c   Liff, Jonathan M ^d   Strom, Brian L ^e   Simon, Michael S ^f   Press, Michael F ^b   McDonald, Jill A ^c   Ursin, Giske ^b,g   Burkman, Ronald T ^h   Deapen, Dennis ^b   Spirtas, Robert ⁱ  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c EMORY UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g UNIVERSITY OF OSLO   (Norway)

^h BAYSTATE MEDICAL CENTER   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; BREAST CANCER; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; ADULT; ALCOHOL DRINKING; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES;

EID: 33744744695     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0881     Document Type: Article

References (36)

1. Bernstein L. The epidemiology of breast cancer. Women Cancer 1998;1S:7-13.
2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
3. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-53.
4. Li CI, Weiss NS, Stanford JL, Daling JR. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 2000;88:2570-7.
5. Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. JAMA 2002;287:734-41.
6. Newcomb PA, Titus-Ernstoff L, Egan KM, et al. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:593-600.
7. Daling JR, Malone KE, Doody DR, et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 2002;95:2455-64.
8. Newcomer LM, Newcomb PA, Potter JD, et al. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 2003;14:225-33.
9. Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003;289:3254-63.
10. Ursin G, Tseng CC, Paganini-Hill A, et al. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 2002;20:699-706.
11. Newcomer LM, Newcomb PA, Trentham-Dietz A, Longnecker MP, Greenberg ER. Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer 2003;106:961-4.
12. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer 2003;107:647-51.
13. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomarkers Prev 2003;12:1061-6.
14. Ursin G, Bernstein L, Lord SJ, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005;93:364-71.
15. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology 1982;6:149-61.
16. Stierer M, Rosen H, Weber R, Hanak H, Spona J, Tuchler H. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg 1993;218:13-21.
17. Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F. Frequent overexpression of the cyclin Dl oncogene in invasive lobular carcinoma of the breast. Cancer Res 1998;58:2876-80.
18. Lee AHS, Dublin EA, Bobrow LG, Poulsom R. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol 1998;185:394-401.
19. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001;115:85-98.
20. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 2003;163:2149-53.
21. Marchbanks PA, McDonald JA, Wilson HG, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 2002;12:213-21.
22. McDonald JA, Mandel MG, Marchbanks PA, et al. Alcohol exposure and breast cancer: results of the Women's Contraceptive and Reproductive Experiences Study. Cancer Epidemiol Biomarkers Prev 2004;13:2106-16.
23. Begg CB, Gray R. Calculation of polychotomous logistic regression parameters using individualized regressions. Biometrika 1984;71:11-8.
24. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemioi 1993;138:923-36.
25. Stalsberg H, Thomas DB, Noonan EA. Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 1989;44:399-409.
26. Abrams TA, Guzman RC, Hirokawa Y, et al. Refractoriness of parous rats to mammary carcinogenesis is overcome by treatment with ovarian hormones. Proc Am Assoc Cancer Res 1997;38:1992.
27. Russo J, Russo IH. Role of differentiation in the pathogenesis and prevention of breast cancer. Endocr Relat Cancer 1997;4:7-12.
28. Sivaraman L, Medina D. Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 2002;7:77-92.
29. Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M. Reproductive risk factors for breast cancer by receptor status, histology, laterality and location, Int J Cancer 1999;81:49-55.
30. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
31. Vainio H, Bianchini F. IARC handbooks on cancer prevention: weight control and physical activity. Lyon: IARC Press; 2002.
32. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-51.
33. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002;87:1234-45.
34. Dorgan JF, Baer DJ, Albert PS, et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710-5.
35. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:R149-56.
36. Korhonen T, Huhtala H, Holli K. A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat 2004;85:23-9.